Cologne, Germany — Singleron Biotechnologies, a leader in single cell multi-omics analysis, is happy to announce the opening of their brand-new laboratories in Cologne, Germany, dedicated to showcasing their vast single cell sequencing solutions, from instruments to novel kits tailored for many different research applications. Through customer demonstrations, these modern laboratories will provide potential customers […]

Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers Simplifies biomarker assay development and validation Creates end-to-end spatial phenotyping workflow when integrated with the PhenoImager platforms MARLBOROUGH, Mass. — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the […]

Company to offer its first-to-market Blazar® Rodent Panel for virus testing Reduces biosafety turnaround time by up to 80% Reduces animal testing through molecular-based technology Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a collaboration with Biotheus, a China-based biotech company […]

Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – and Visiopharm today announced a collaboration to pair the company’s Hyperion™ and Hyperion+™ Imaging Systems with Visiopharm Phenoplex™ analysis software for simplified image processing and enhanced spatial pathology insights, building on the success of a co-marketing agreement announced last year. Visiopharm, a […]

MENLO PARK, CA – LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis. The funding allows LevitasBio to accelerate its commercial success through the development […]

TEL AVIV, Israel — Nucleai, a leader in AI-powered spatial biology, today announced the expansion of its spatial biology platform to include a new generation of multiplex immunofluorescence (mIF) analysis that uses deep learning to establish new levels of accuracy, speed, and generalizability, further unlocking the power of mIF data for drug discovery and development. […]

First commercial kit to quantify protein modification in single cells launched by Singleron Biotechnologies Cologne, Germany — Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions, announces the launch of the first commercially available product that can quantify protein glycosylation at single cell level, ProMoSCOPE™ kit.  This product uses a […]

ATCC to provide more physiologically relevant immuno-oncology tools for better reproducibility and improved in vitro targeting to facilitate the advancement of novel cancer treatments. MANASSAS, Va. — ATCC, the world’s premier biological materials management and standards organization, today announced a new line of products, CAR-T Target luciferase reporter cell lines, that will support immuno-oncology (IO) discovery […]

ATCC Cell Line Land allows use of cell cultures without lengthy and costly gene sequencing  Database provides information about actual lots of cell lines stored in ATCC’s biorepository QDI is committed to providing customers the most comprehensive manually curated content Redwood City, California, and Hilden, Germany — QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, […]

Accomplished scientist and business executive brings nearly two decades of experience working on commercial strategies and operations in life sciences MENLO PARK, Calif. — Ionpath, a pioneer in high-definition spatial proteomics, announced today that Goran Pljevaljcic has joined the company as its Chief Commercial Officer. In this position, he will spearhead Ionpath’s commercial activities, including […]